HomeFileStructural heart disease

Structural heart disease

Post TAVR Dialysis: a Severe Complication Less and Less Frequent

The prevalence of pre-procedural kidney failure in patients undergoing transcatheter aortic valve replacement (TAVR) can be as high as...

Colombia Sessions: Contest for Young Interventionists

Sponsored by Abbott Vascular LATAM 34th SOLACI Regional Sessions – 11° Andrean Region. October 5th and 6th, 2017. Bogotá, Colombia. Case Submission: “Fostering...

Bleeding and Mortality in Transcatheter Aortic Valve Replacement

Transcatheter aortic valve replacement (TAVR) is much less invasive than surgical replacement. This is associated with a substantial...

How to standardize frailty in aortic stenosis patients

Frailty is the patient’s diminished capacity to recover after pathological or iatrogenic processes. It has a fundamental...

Incomplete Revascularization Is Associated with Mortality in TAVR

Courtesy of Dr. Carlos Fava. TAVR has proven to be beneficial for inoperable and high-risk patients, as well as...

Valve Deterioration after TAVI Is Rare and Should Not Prevent Advancement to Younger Populations

Durability ─or better yet, lack of deterioration─ is still a matter of debate when considering transcatheter aortic...

ProEducar’s Course José Gabay Successfully Completed

The eight month of this year saw a scientific event of utmost importance to the community of...

SOLACI CACI 2017 | When is the optimal timing for PCI: before or during TAVI

Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Conrad...